Skip to main content
. 2015 Mar;6(3-4):119–128. doi: 10.18632/genesandcancer.56

Figure 5. RRM1 and ERCC1 immunoreactivity correlated to proportion of effective drugs and survival time.

Figure 5

A: Proportion of effective drugs plotted against RRM1 staining. B: Survival time plotted against RRM1. C: Proportion of effective drugs plotted against ERCC1 staining. D: Survival time plotted against ERCC1. Regression analyses presented in red, data points for each patient in blue. Statistically significant departure of the slope from 0 was accepted at p<0.05 and was not seen.